Most in vitro diagnostics (IVD) companies reported increases in base business during the third quarter (Q3) 2023. The numbers, in the single digits, softened the blow from the continuing drop-off in COVID-19 test sales. Manufacturers of tests and laboratory instruments are launching new diagnostics solutions, making greater use of technology, and eyeing possible acquisitions as …
Most IVD Firms Increase Q3 2023 Base Business Revenue Read More »
